SARS-CoV-2 Omicron: a new challenge for pandemic and vaccine

por Zhang, Xiantao, Zhang, Hui, He, Xin
Publicado 2022

Preferences for WeChat-Based and Hospital-Based Family Intervention Among Caregivers of People Living with Schizophrenia

por Zhang, Xiantao, Liu, Bibo, Zang, Difan, Li, Yilu, Xiao, Shuiyuan, Yu, Yu
Publicado 2022

A Triterpenoid from Thalictrum fortunei Induces Apoptosis in BEL-7402 Cells Through the P53-Induced Apoptosis Pathway

por Zhang, Xiantao, Zhao, Ming, Chen, Lvyi, Jiao, Haoyan, Liu, Hongxia, Wang, Liyan, Ma, Shuwei
Publicado 2011

SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance

por Zhang, Xiantao, Wu, Shijian, Wu, Bolin, Yang, Qirui, Chen, Achun, Li, Yuzhuang, Zhang, Yiwen, Pan, Ting, Zhang, Hui, He, Xin
Publicado 2021

Improvement of a SARS-CoV-2 vaccine by enhancing the conjugation efficiency of the immunogen to self-assembled nanoparticles

por Zhang, Xiantao, Yuan, Yaochang, Wu, Bolin, Wang, Xuemei, Lin, Yingtong, Luo, Yuewen, Li, Rong, Chen, Tao, Deng, Jieyi, Zhang, Xu, Zou, Fan, He, Xin, Zhang, Hui
Publicado 2021

Engineering a Reliable and Convenient SARS-CoV-2 Replicon System for Analysis of Viral RNA Synthesis and Screening of Antiviral Inhibitors

por Luo, Yuewen, Yu, Fei, Zhou, Mo, Liu, Yang, Xia, Baijin, Zhang, Xiantao, Liu, Jun, Zhang, Junsong, Du, Yingying, Li, Rong, Wu, Liyang, Zhang, Xu, Pan, Ting, Guo, Deyin, Peng, Tao, Zhang, Hui
Publicado 2021

Infection of wild-type mice by SARS-CoV-2 B.1.351 variant indicates a possible novel cross-species transmission route

por Pan, Ting, Chen, Ran, He, Xin, Yuan, Yaochang, Deng, Xiaohui, Li, Rong, Yan, Haiping, Yan, Shumei, Liu, Jun, Zhang, Yiwen, Zhang, Xiantao, Yu, Fei, Zhou, Mo, Ke, Changwen, Ma, Xiancai, Zhang, Hui
Publicado 2021

USP10 regulates B cell response to SARS-CoV-2 or HIV-1 nanoparticle vaccines through deubiquitinating AID

por Luo, Yuewen, Zhang, Xiantao, Chen, Ran, Li, Rong, Liu, Yang, Zhang, Junsong, liu, Qin, Si, Meijun, Liu, Jun, Wu, Bolin, Wang, Xuemei, Wu, Shijian, Zhang, Yiwen, Zhang, Xu, Guo, Deyin, He, Xin, Pan, Ting, Zhang, Hui
Publicado 2022

A Mosaic Nanoparticle Vaccine Elicits Potent Mucosal Immune Response with Significant Cross‐Protection Activity against Multiple SARS‐CoV‐2 Sublineages

por Zhang, Xiantao, Wu, Shijian, Liu, Jie, Chen, Ran, Zhang, Yongli, Lin, Yingtong, Xi, Zhihui, Deng, Jieyi, Pu, Zeyu, Liang, Chaofeng, Feng, Jinzhu, Li, Rong, Lin, Keming, Zhou, Mo, Liu, Yingying, Zhang, Xu, Liu, Bingfeng, Zhang, Yiwen, He, Xin, Zhang, Hui
Publicado 2023

Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses

por Ma, Xiancai, Zou, Fan, Yu, Fei, Li, Rong, Yuan, Yaochang, Zhang, Yiwen, Zhang, Xiantao, Deng, Jieyi, Chen, Tao, Song, Zheng, Qiao, Yidan, Zhan, Yikang, Liu, Jun, Zhang, Junsong, Zhang, Xu, Peng, Zhilin, Li, Yuzhuang, Lin, Yingtong, Liang, Liting, Wang, Guanwen, Chen, Yingshi, Chen, Qier, Pan, Ting, He, Xin, Zhang, Hui
Publicado 2020

A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2

por Yuan, Yaochang, Zhang, Xiantao, Chen, Ran, Li, Yuzhuang, Wu, Bolin, Li, Rong, Zou, Fan, Ma, Xiancai, Wang, Xuemei, Chen, Qier, Deng, Jieyi, Zhang, Yongli, Chen, Tao, Lin, Yingtong, Yan, Shumei, Zhang, Xu, Li, Congrong, Bu, Xiuqing, Peng, Yi, Ke, Changwen, Deng, Kai, Pan, Ting, He, Xin, Zhang, Yiwen, Zhang, Hui
Publicado 2022

Development of Receptor Binding Domain (RBD)‐Conjugated Nanoparticle Vaccines with Broad Neutralization against SARS‐CoV‐2 Delta and Other Variants

por Chen, Ran, Zhang, Xiantao, Yuan, Yaochang, Deng, Xiaohui, Wu, Bolin, Xi, Zhihui, Wang, Guanwen, Lin, Yingtong, Li, Rong, Wang, Xuemei, Zou, Fan, Liang, Liting, Yan, Haiping, Liang, Chaofeng, Li, Yuzhuang, Wu, Shijian, Deng, Jieyi, Zhou, Mo, Zhang, Xu, Li, Congrong, Bu, Xiuqing, Peng, Yi, Ke, Changwen, Deng, Kai, He, Xin, Zhang, Yiwen, Zhang, Zhenhai, Pan, Ting, Zhang, Hui
Publicado 2022